Vesta Therapeutics Inc is categorized under Commercial Biotechnical Research in Halethorpe, MD and active since 2002.
Vesta Therapeutics Inc was established in 2002, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Mark Johnston at the company’s single location by writing to 1448 South Rolling Road, Halethorpe, Maryland MD 21227 or by phoning (804) 377-3580. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Vesta Therapeutics Inc |
| Contact Person: | Mark Johnston |
| Address: | 1448 South Rolling Road, Halethorpe, Maryland 21227 |
| Phone Number: | (804) 377-3580 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Vesta Therapeutics Inc was started in 2002 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Mark Johnston for inquiries that concern Vesta Therapeutics Inc by calling the company number (804) 377-3580, as your correspondence is most welcome. Additionally, the physical location of the single location of Vesta Therapeutics Inc can be found at the coordinates 39.23705,-76.713612 as well as the street address 1448 South Rolling Road in Halethorpe, Maryland 21227.
For its online presence, you may visit Vesta Therapeutics Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.